TradingView
TheCryptoChartWhisperer
Mar 10, 2022 10:05 PM

IFRX 1D Continued Long

InflaRx N.V.NASDAQ

Description

test
Just having some fun after a great ski trip to Breckenridge, Co for a couple of weeks. Let's get back into it.

InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a. Its products include IFX-1 and IFX-2. The company was founded by Niels Christoph Riedemann, Renfeng Guo and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.

Trade closed: target reached

More